Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial

Published:2022-01 Issue: Volume:34 Page:3-10
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Iglesias Juan F.,Heg Dik,Roffi Marco,Degrauwe Sophie,Tüller David,Muller Olivier,Brinkert Miriam,Cook Stéphane,Weilenmann Daniel,Kaiser Christoph,Cuculi Florim,Valgimigli Marco,Jüni Peter,Windecker Stephan,Pilgrim Thomas

Funder

Abbott Vascular

Bayer

Daiichi-Sankyo

Medtronic

BIOTRONIK SE und Co KG

Terumo

AstraZeneca

Boston Scientific Corporation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference22 articles.

1. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Collet;Eur Heart J,2021

2. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

3. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial;Sabaté;Lancet,2016

4. Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction

5. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials;Bangalore;Circ Cardiovasc Interv,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes;Catheterization and Cardiovascular Interventions;2023-12-13

2. 48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent;Journal of Personalized Medicine;2023-11-03

3. Long‐term safety of ultrathin bioabsorbable‐polymer sirolimus‐eluting stents versus thin durable‐polymer drug‐eluting stents in acute coronary syndrome: A systematic review and meta‐analysis;Clinical Cardiology;2023-09-03

4. The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy;Journal of the Society for Cardiovascular Angiography & Interventions;2023-05

5. Have Stents Gone About as Far as They Can Go?;Cardiovascular Revascularization Medicine;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3